APLS
Apellis Pharmaceuticals Inc.
$24.50
-$0.62(-2.47%)
51
Overall
40
Value
63
Tech
50
Quality
Market Cap
$3.18B
Volume
904.53K
52W Range
$16.10 - $35.72
Target Price
$37.44
Key Metrics Overview
| Market Cap | $3.18B | P/E Ratio | N/A |
| 52W High | $35.72 | 52W Low | $16.10 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 43.4% | 52W Position | 42.8% |
| Overall Score | 51 | Value Score | 40 |
| Quality Score | 50 | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-0.66 | EPS Next Est | $-1.05 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APLS | $24.50 | -2.5% | 904.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apellis Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW